Tumor MGMT promoter hypermethylation changes over time limit temozolomide efficacy in a phase II trial for metastatic colorectal cancer
Amatu, A., Barault, L., Moutinho, C., Cassingena, A., Bencardino, K., Ghezzi, S., Palmeri, L., Bonazzina, E., Tosi, F., Ricotta, R., Cipani, T., Crivori, P., Gatto, R., Chirico, G., Marrapese, G., TruLanguage:
english
Journal:
Annals of Oncology
DOI:
10.1093/annonc/mdw071
Date:
February, 2016
File:
PDF, 694 KB
english, 2016